RLMD
RELMADA THERAPEU (RLMD)
NASDAQ
$4.56+$0.04 (+0.97%)
Price as of Sep 11, 2026 7:59 PM EDT
  • $482.1M
    Market Cap
  • 184.28%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 38
Valuation
RLMD
vs History
vs S&P 500
Profitability
-1
Growth
0
Low Earnings Volatility
1

Momentum Score

Score: 22
Valuation
RLMD
vs History
vs S&P 500
3-Month Momentum
-24.72%
12-Month Momentum
210.53%
3-Month Risk Adjusted Momentum
-97.22%
12-Month Risk Adjusted Momentum
205.73%

True Yield

N/A
Valuation
RLMD
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
1.35%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 89
Valuation
RLMD
vs History
vs S&P 500
Ohlson's O-Score
-2